Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Mullick A, Elias M, Picard S, Bourget L, Jovcevski O, Gauthier S, Tuite A, Harakidas P, Bihun C, Massie B, Gros P.

Infect Immun. 2004 Oct;72(10):5868-76.

2.

Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans.

Mullick A, Elias M, Harakidas P, Marcil A, Whiteway M, Ge B, Hudson TJ, Caron AW, Bourget L, Picard S, Jovcevski O, Massie B, Thomas DY.

Infect Immun. 2004 Jan;72(1):414-29.

3.

Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a syngeneic model of rat prostate cancer in vivo.

Rabbani SA, Harakidas P, Guo Y, Steinman D, Davidsen SK, Morgan DW.

Int J Cancer. 2000 Jul 15;87(2):276-82.

4.

Regulated expression of HIV-1 Rev function in mammalian cell lines.

Swenarchuk L, Harakidas P, Cochrane A.

Can J Microbiol. 1999 Jun;45(6):480-90.

PMID:
10453476
5.
6.

Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.

Rabbani SA, Harakidas P, Bowlin T, Attardo G.

Cancer Res. 1998 Aug 1;58(15):3461-5.

7.

Expression and characterization of recombinant rat parathyroid hormone-related peptide (1-141) and an amino-terminally-truncated analogue (38-141).

Rabbani SA, Harakidas P, Gladu J, Srivastava S, Diarra A, Sauvé R, Karaplis AC, Henderson JE, Goltzman D, Hendy GN.

Mol Cell Endocrinol. 1997 Jun 20;130(1-2):13-21.

PMID:
9220017
8.

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

Rabbani SA, Harakidas P, Davidson DJ, Henkin J, Mazar AP.

Int J Cancer. 1995 Dec 11;63(6):840-5.

PMID:
8847143

Supplemental Content

Loading ...
Support Center